Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ben Creavin

12PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersHaematological tumoursApplied theatre
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

Sort by Publication Date:
|Mar 10, 2026
Evaluating the impact of GLP-1 receptor agonists in combination with total neoadjuvant therapy for locally advanced rectal cancer.

Hugo C Temperley, Matthew Coalter, Ben Creavin

|Dec 24, 2025
Outcomes Following Colorectal Cancer Resection in Elderly Patients.

Richard Grainger, Tatiana S Temperley, Hugo C Temperley

|Jun 18, 2023
Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.

Mark Donnelly, Odhrán K Ryan, Éanna J Ryan

|May 31, 2023
Mechanical bowel preparation and antibiotics in elective colorectal surgery: network meta-analysis.

Jonavan Tan, Éanna J Ryan, Matthew G Davey

|Jun 30, 2022
Risk of pancreatic ductal adenocarcinoma associated with carriage of BRCA1 and/or BRCA2 mutation: A systematic review and meta-analysis.

Jennifer L McGarry, Ben Creavin, Michael E Kelly

|Mar 22, 2021
Oncological outcomes of laparoscopic versus open rectal cancer resections: meta-analysis of randomized clinical trials.

B Creavin, M E Kelly, É J Ryan

Pageof 2

Frequent Collaborators

5 joint publications

Michael E Kelly

4 joint publications

Éanna J Ryan

2 joint publications

Odhrán K Ryan

2 joint publications

Hugo C Temperley

1 joint publications

J H Lefevre

1 joint publications

A M Zaborowski

1 joint publications

A C Rogers

1 joint publications

C M Cullinane

1 joint publications

Jennifer L McGarry

1 joint publications

Mark Donnelly

Frequent Collaborators

5 joint publications

Michael E Kelly

4 joint publications

Éanna J Ryan

2 joint publications

Odhrán K Ryan

2 joint publications

Hugo C Temperley

Top Related Videos

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on : Feb 12, 2022

6.8K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

619
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

509
See more related videos

Top Related Videos

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on : Feb 12, 2022

6.8K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

619
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

509
See more related videos